Advance precision therapies and diagnostics with real-world data
Proscia is enabling life sciences to accelerate critical milestones with the power of pathology images matched to clinical and genomic data at scale.
READ: INTRODUCING PROSCIA APERTURE–DATA AT THE POINT OF DIAGNOSIS
A powerful new data modality unlocking precision medicine breakthroughs
Proscia helps life sciences access and fully leverage multimodal, targeted, structured data from one of the fastest growing databases in healthcare – powering research insights and AI model traning. Data includes de-identified whole slide images, histopathology reports, molecular and genomic profiles, clinical records, and more.
2M+
patients and growing
100K+
whole slide images with matched molecular profiles
10K+
whole slide images added / day
How pathology data helps life sciences accelerate every stage of next-generation drug discovery and development
Discover biomarkers
Discover novel biomarkers that predict disease progression and treatment response
Identify targets
Study disease mechanisms to identify new therapeutic targets or match an existing drug asset with new indications
Train Models
Build high-performing AI models with extensive data spanning diverse populations, disease states, and outcomes beyond controlled clinical trial data
Develop diagnostics
Develop innovative AI-based biomarkers, diagnostics, and pre-screening tools for treatment response prediction and stratification
Optimize trials
Enhance patient enrollment and endpoint assessments by developing AI models that provide quantifiable measures of progression and treatment response
Expedite analysis
Speed up overall research study timelines by building AI algorithms that assist pathologists in reviewing images more efficiently
Multimodal, Targeted, Structured Data Ready for Discovery and Development
MULTIMODAL
Gain deeper, actionable insights with clinical and molecular context
Maximize data value with a comprehensive view of each patient that captures the complexity of disease.
- Rely on thorough characterization of every patient with clinically relevant data
- Utilize tokenization to securely link Proscia data with existing datasets, providing a holistic view of the patient journey
- Optimize AI and machine learning algorithm development with diverse data modalities
TARGETED
Access data cohorts aligned to your development needs
The depth and breadth required to deliver targeted cohorts highly relevant to specific AI model development and research requirements.
- Reduce bias and improve model generalizability with cohorts that reflect the heterogeneity clinical trial data often lacks
- Disease area, biomarker, or anatomic-site based cohorts
- Therapeutic area coverage across oncology, immunology, and cardiometabolic diseases
- Representative patient distribution across stages of disease to augment narrow clinical trial populations
STRUCTURED
Develop with confidence using research-ready, high-quality data
Proscia’s data is standardized and cleaned to meet rigorous quality thresholds, ensuring immediate usability while eliminating the onerous tasks that delay time to insight. To date, we have fulfilled project requests ranging from thousands to millions of slides across 98 anatomic sites, with an average assembly and delivery time of 4–6 weeks.
- Stringent data quality standards meet the high thresholds required for AI model building
- Every image is screened by Proscia’s Automated Quality Control (QC) AI application before delivery. In a recent large-scale delivery, 96% of images met or exceeded the quality thresholds required for model training
- Complex histopathology reports and other unstructured data types are cleaned and normalized through advanced AI and machine learning methods
- Data is meticulously prepared to support regulatory submission guidelines – critical for teams building AI-based diagnostics destined for FDA/CE review
Get from data to insights faster with Concentriq®
Data is delivered directly in the enterprise pathology platform that unifies pathology data, workflows, teams, and applications, allowing your organization to maximize its value.
- Seamlessly incorporate data into existing model training pipelines and studies
- Instantly run AI applications from Proscia’s precision medicine AI portfolio to analyze data
- Leverage the data to develop proprietary AI models that can impact numerous milestones from discovery to development
- Meet FAIR data principles enabling more departments and teams to leverage the data, driving faster innovation and decision-making across the R&D organization
- Securely share data and insights with collaborators and other compute platforms
Explore Real-World Data Resources
Explore Real-World Data Resources
Webinar
GEN NEWS: Pathology Data: The Missing Link in Accelerating Precision Medicine
Webinar
From Bedside to Bench and Back: How Digital Pathology is Fueling Precision Medicine with Unprecedented Real-World Data with PathGroup and Genentech
Ready to accelerate your therapeutic development program and model training with multimodal real-world data?
Connect with us today to learn how Proscia’s data can help drive your next precision medicine breakthrough.